GLYDT_BPPM6
ID GLYDT_BPPM6 Reviewed; 291 AA.
AC P0DTK6;
DT 03-AUG-2022, integrated into UniProtKB/Swiss-Prot.
DT 03-AUG-2022, sequence version 1.
DT 03-AUG-2022, entry version 1.
DE RecName: Full=Glycinyltransferase {ECO:0000305};
DE AltName: Full=Amino acid:DNA transferase {ECO:0000303|PubMed:34522950};
DE Short=AADT {ECO:0000303|PubMed:34522950};
DE AltName: Full=gp51 {ECO:0000303|PubMed:34522950};
OS Pseudomonas phage M6.
OC Viruses; Duplodnaviria; Heunggongvirae; Uroviricota; Caudoviricetes;
OC Caudovirales; Siphoviridae; Yuavirus.
OX NCBI_TaxID=2911432;
OH NCBI_TaxID=287; Pseudomonas aeruginosa.
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=16428425; DOI=10.1128/jb.188.3.1184-1187.2006;
RA Kwan T., Liu J., Dubow M., Gros P., Pelletier J.;
RT "Comparative genomic analysis of 18 Pseudomonas aeruginosa
RT bacteriophages.";
RL J. Bacteriol. 188:1184-1187(2006).
RN [2]
RP FUNCTION.
RX PubMed=29555775; DOI=10.1073/pnas.1714812115;
RA Lee Y.J., Dai N., Walsh S.E., Mueller S., Fraser M.E., Kauffman K.M.,
RA Guan C., Correa I.R. Jr., Weigele P.R.;
RT "Identification and biosynthesis of thymidine hypermodifications in the
RT genomic DNA of widespread bacterial viruses.";
RL Proc. Natl. Acad. Sci. U.S.A. 115:E3116-E3125(2018).
RN [3]
RP FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF GLU-243 AND CYS-247.
RX PubMed=34522950; DOI=10.1093/nar/gkab781;
RA Lee Y.J., Dai N., Mueller S.I., Guan C., Parker M.J., Fraser M.E.,
RA Walsh S.E., Sridar J., Mulholland A., Nayak K., Sun Z., Lin Y.C.,
RA Comb D.G., Marks K., Gonzalez R., Dowling D.P., Bandarian V., Saleh L.,
RA Correa I.R., Weigele P.R.;
RT "Pathways of thymidine hypermodification.";
RL Nucleic Acids Res. 0:0-0(2021).
CC -!- FUNCTION: Transfers glycine to 5-phosphomethyl-2'-deoxyuridine (5-PmdU)
CC to produce 5-Nalpha-glycinylthymidine (Nalpha-GlyT) as a step in the
CC pathway leading to thymidine hypermodifications in the viral genome
CC (PubMed:34522950). As a final result of the pathway of
CC hypermodification, 5-aminoethyl-2'-deoxyuridine (5-NedU) substitutes
CC for about 30% of thymidines in the viral DNA (PubMed:34522950,
CC PubMed:29555775). These modifications probably prevent degradation of
CC viral genome by the host restriction-modification antiviral defense
CC system (PubMed:34522950). {ECO:0000269|PubMed:29555775,
CC ECO:0000269|PubMed:34522950}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=5-phosphomethyl-dUMP in DNA + glycine = 5-N(alpha)-glycyl-dTMP
CC in DNA + phosphate; Xref=Rhea:RHEA:71547, Rhea:RHEA-COMP:18039,
CC Rhea:RHEA-COMP:18040, ChEBI:CHEBI:43474, ChEBI:CHEBI:57305,
CC ChEBI:CHEBI:190918, ChEBI:CHEBI:190919;
CC Evidence={ECO:0000269|PubMed:34522950};
CC -!- SIMILARITY: Belongs to the thymidine aminotransferase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; DQ163916; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR RefSeq; YP_001294559.1; NC_007809.1.
PE 1: Evidence at protein level;
KW Host-virus interaction; Restriction-modification system evasion by virus;
KW Transferase.
FT CHAIN 1..291
FT /note="Glycinyltransferase"
FT /id="PRO_0000456272"
FT ACT_SITE 243
FT /evidence="ECO:0000305|PubMed:34522950"
FT MUTAGEN 243
FT /note="E->A: Complete loss of enzymatic activity."
FT /evidence="ECO:0000269|PubMed:34522950"
FT MUTAGEN 247
FT /note="C->A: Complete loss of enzymatic activity."
FT /evidence="ECO:0000269|PubMed:34522950"
SQ SEQUENCE 291 AA; 33462 MW; 5E6FA65ADF204146 CRC64;
MSRNYPRLDI ETFGRHLITT GDLDPIYTAL VRAEEAGDFS VPQLCRWLLG YWCYYHAGVA
SFLSEKEGEE FWHWMMVAAR NEEETPAGGR WPRGHERRHY RAKIAVDSVT SLQARYGDRP
ENMALYVGAR ATEDERLPFR TVSARAQEHN GFGPWIGFKI ADMMDRVMEV PVDFDNAAVF
MFKDPEKAAM MLWEQREAHK YPENAKPKRE AILSGVADYL IGRFADLAAP PLSDRPVNIQ
EVETVLCKWK SHMNGHYPLW NDIREINGGL EPWAGRCSAA RAFLNHMPKE Q